China Pharma Holdings, Inc. SEC filings CPHI

China Pharma Holdings, Inc. has 426 filings in SEC EDGAR's recent list, going back to Feb 15, 2000. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 22, 2026 (material agreement, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
PRE 14A Preliminary proxy statement Oct 30, 2026 Oct 30, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
424B5 Prospectus supplement Jul 23, 2026 —
8-K Current report
Material agreement, Other events
 Jul 22, 2026 Jul 22, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-K Annual report Apr 1, 2026 Dec 31, 2025
NT 10-K Notification of late filing Apr 1, 2026 Dec 31, 2025
8-K Current report
Material agreement, Unregistered share sale
 Mar 3, 2026 Feb 26, 2026
8-K Current report
Material agreement, Unregistered share sale
 Feb 10, 2026 Feb 5, 2026
8-K Current report
Shareholder vote results
 Jan 6, 2026 Dec 30, 2025
8-K Current report
Material agreement, Unregistered share sale
 Dec 23, 2025 Dec 22, 2025
8-K Current report
Material agreement, Unregistered share sale
 Dec 10, 2025 Dec 4, 2025
DEF 14A Proxy statement Nov 14, 2025 Dec 30, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
PRE 14A Preliminary proxy statement Nov 4, 2025 Nov 4, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Regulation FD disclosure
 Apr 4, 2025 Apr 4, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Agreement ended
 Dec 26, 2024 Dec 23, 2024
8-K Current report
Shareholder vote results
 Dec 26, 2024 Dec 22, 2024
8-K Current report
Material agreement
 Dec 13, 2024 Dec 12, 2024
424B5 Prospectus supplement Dec 13, 2024 —
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
DEF 14A Proxy statement Nov 12, 2024 Dec 22, 2024
PRE 14A Preliminary proxy statement Nov 1, 2024 Nov 1, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Material agreement
 May 30, 2024 May 23, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Auditor change
 May 8, 2024 May 7, 2024
10-K Annual report Apr 1, 2024 Dec 31, 2023
8-K Current report
Other events
 Mar 29, 2024 Mar 27, 2024
8-K Current report
Regulation FD disclosure
 Feb 23, 2024 Feb 23, 2024
EFFECT Filing Feb 14, 2024 —
CORRESP Letter to the SEC Feb 14, 2024 —
8-K Current report
Material agreement, Unregistered share sale
 Feb 8, 2024 Feb 2, 2024
CORRESP Letter to the SEC Feb 6, 2024 —
S-3/A Amendment no. 1 to form s-3 Feb 6, 2024 —
UPLOAD Letter from the SEC Jan 25, 2024 —
S-3 Shelf registration Jan 12, 2024 —
8-K Current report
Material agreement, Unregistered share sale
 Dec 21, 2023 Dec 15, 2023
8-K Current report
Shareholder vote results, Other events
 Dec 19, 2023 Dec 15, 2023
UPLOAD Letter from the SEC Nov 16, 2023 —
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
CORRESP Letter to the SEC Nov 9, 2023 —
DEF 14A Proxy statement Nov 7, 2023 Dec 18, 2023
PRE 14A Preliminary proxy statement Oct 27, 2023 Oct 27, 2023
UPLOAD Letter from the SEC Oct 27, 2023 —
CORRESP Letter to the SEC Oct 18, 2023 —
8-K Current report
Listing notice
 Oct 3, 2023 Sep 27, 2023
UPLOAD Letter from the SEC Sep 26, 2023 —
CORRESP Letter to the SEC Sep 8, 2023 —
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
UPLOAD Letter from the SEC Jul 25, 2023 —
10-Q Quarterly report May 12, 2023 Mar 31, 2023
8-K Current report
Material agreement
 Apr 20, 2023 Apr 13, 2023
10-K Annual report Mar 30, 2023 Dec 31, 2022
8-K Current report
Other events
 Mar 29, 2023 Mar 27, 2023
8-K Current report
Regulation FD disclosure
 Feb 24, 2023 Feb 24, 2023
8-K Current report
Shareholder vote results
 Dec 30, 2022 Dec 27, 2022
8-K Current report
Material agreement, Unregistered share sale
 Dec 2, 2022 Nov 28, 2022
8-K Current report
Listing notice
 Dec 2, 2022 Dec 1, 2022
DEF 14A Proxy statement Nov 14, 2022 Dec 28, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
PRE 14A Preliminary proxy statement Nov 4, 2022 Dec 28, 2022
S-8 Employee stock plan registration Oct 24, 2022 —
8-K Current report
Listing notice
 Sep 30, 2022 Sep 26, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Listing notice
 Jun 22, 2022 Jun 15, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
10-K Annual report Mar 30, 2022 Dec 31, 2021
8-K Current report
Shareholder vote results
 Dec 29, 2021 Dec 26, 2021
424B5 Prospectus supplement Dec 16, 2021 —
D Filing Nov 29, 2021 —
8-K Current report
Material agreement, New debt
 Nov 23, 2021 Nov 17, 2021
DEFA14A Additional proxy material Nov 15, 2021 —
DEF 14A Proxy statement Nov 15, 2021 Dec 27, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
8-K Current report
Officer or director change
 Sep 15, 2021 Sep 9, 2021
10-Q Quarterly report Aug 13, 2021 Jun 30, 2021
10-Q Quarterly report May 14, 2021 Mar 31, 2021
10-K Annual report Mar 26, 2021 Dec 31, 2020
EFFECT Filing Jan 21, 2021 —
CORRESP Letter to the SEC Jan 19, 2021 —
UPLOAD Letter from the SEC Jan 15, 2021 —
S-3 Shelf registration Jan 8, 2021 —
8-K Current report
Officer or director change, Shareholder vote results
 Dec 29, 2020 Dec 23, 2020
S-8 Employee stock plan registration Dec 21, 2020 —
DEFA14A Additional proxy material Nov 16, 2020 —
DEF 14A Proxy statement Nov 16, 2020 Dec 28, 2020
10-Q Quarterly report Nov 13, 2020 Sep 30, 2020
10-Q Quarterly report Aug 13, 2020 Jun 30, 2020
10-Q Quarterly report May 14, 2020 Mar 31, 2020
10-K Annual report Mar 30, 2020 Dec 31, 2019
8-K Current report
Shareholder vote results
 Dec 23, 2019 Dec 19, 2019
10-Q Quarterly report Nov 14, 2019 Sep 30, 2019
DEFA14A Additional proxy material Nov 6, 2019 —
DEF 14A Proxy statement Nov 6, 2019 Dec 19, 2019
10-Q Quarterly report Aug 14, 2019 Jun 30, 2019
10-Q Quarterly report May 14, 2019 Mar 31, 2019
10-K Annual report Mar 28, 2019 Dec 31, 2018
8-K Current report
Shareholder vote results
 Dec 6, 2018 Dec 4, 2018
10-Q Quarterly report Nov 14, 2018 Sep 30, 2018
DEFA14A Additional proxy material Oct 25, 2018 —
DEF 14A Proxy statement Oct 25, 2018 Dec 5, 2018
10-Q Quarterly report Aug 14, 2018 Jun 30, 2018
10-Q Quarterly report May 14, 2018 Mar 31, 2018
10-K Annual report Apr 2, 2018 Dec 31, 2017
8-K Current report
Other events
 Mar 12, 2018 Mar 6, 2018
8-K Current report
Shareholder vote results
 Dec 18, 2017 Dec 14, 2017
10-Q Quarterly report Nov 14, 2017 Sep 30, 2017
DEFA14A Additional proxy material Nov 3, 2017 —
DEF 14A Proxy statement Nov 3, 2017 Dec 14, 2017
8-K Current report
Listing notice
 Sep 12, 2017 Sep 6, 2017
10-Q Quarterly report Aug 14, 2017 Jun 30, 2017
10-Q Quarterly report May 11, 2017 Mar 31, 2017
10-K Annual report Mar 31, 2017 Dec 31, 2016
8-K Current report
Results of operations
 Mar 31, 2017 Mar 31, 2017
8-K Current report
Other events
 Dec 28, 2016 Dec 22, 2016
8-K Current report
Shareholder vote results
 Dec 13, 2016 Dec 8, 2016
8-K Current report
Auditor change
 Dec 2, 2016 Nov 28, 2016
10-Q Quarterly report Nov 14, 2016 Sep 30, 2016
DEFA14A Additional proxy material Oct 28, 2016 —
DEF 14A Proxy statement Oct 28, 2016 Dec 8, 2016
10-Q Quarterly report Aug 11, 2016 Jun 30, 2016
10-Q Quarterly report May 16, 2016 Mar 31, 2016
10-K Annual report Mar 30, 2016 Dec 31, 2015
10-Q/A Amended quarterly report Dec 28, 2015 Sep 30, 2015
10-Q/A Amended quarterly report Dec 28, 2015 Jun 30, 2015
10-Q/A Amended quarterly report Dec 28, 2015 Mar 31, 2015
10-K/A Amended annual report Dec 28, 2015 Dec 31, 2014
8-K Current report
Restatement
 Dec 11, 2015 Dec 8, 2015
8-K Current report
Shareholder vote results
 Dec 10, 2015 Dec 8, 2015
10-Q Quarterly report Nov 16, 2015 Sep 30, 2015
DEFA14A Additional proxy material Oct 29, 2015 —
DEF 14A Proxy statement Oct 29, 2015 Dec 8, 2015
10-Q Quarterly report Aug 14, 2015 Jun 30, 2015
10-Q Quarterly report May 11, 2015 Mar 31, 2015
10-K Annual report Mar 30, 2015 Dec 31, 2014
8-K Current report
Shareholder vote results
 Dec 31, 2014 Dec 29, 2014
DEFA14C China pharma holdings Nov 21, 2014 —
DEF 14A Proxy statement Nov 20, 2014 Dec 29, 2014
10-Q Quarterly report Nov 14, 2014 Sep 30, 2014
10-Q Quarterly report Aug 14, 2014 Jun 30, 2014
10-Q Quarterly report May 15, 2014 Mar 31, 2014
10-K Annual report Mar 20, 2014 Dec 31, 2013
8-K Current report
Shareholder vote results
 Dec 17, 2013 Dec 16, 2013
10-Q Quarterly report Nov 14, 2013 Sep 30, 2013
DEFA14A Additional proxy material Nov 6, 2013 —
DEF 14A Proxy statement Nov 6, 2013 Dec 16, 2013
8-K Current report
Auditor change
 Oct 15, 2013 Oct 10, 2013
8-K Current report
Auditor change
 Sep 4, 2013 Sep 1, 2013
10-Q Quarterly report Aug 14, 2013 Jun 30, 2013
10-Q Quarterly report May 14, 2013 Mar 31, 2013
10-K Annual report Mar 14, 2013 Dec 31, 2012
8-K Current report
Material agreement, Change to shareholder rights
 Jan 4, 2013 Dec 31, 2012
8-K Current report
Shareholder vote results
 Dec 26, 2012 Dec 21, 2012
DEF 14A Proxy statement Nov 19, 2012 Dec 21, 2012
10-Q Quarterly report Nov 14, 2012 Sep 30, 2012
PRE 14A Preliminary proxy statement Nov 9, 2012 Nov 14, 2012
10-Q Quarterly report Aug 14, 2012 Jun 30, 2012
10-Q Quarterly report May 14, 2012 Mar 31, 2012
8-K Current report
Officer or director change
 Apr 30, 2012 Sep 30, 2011
10-K Annual report Mar 14, 2012 Dec 31, 2011
UPLOAD Letter from the SEC Mar 7, 2012 —
10-Q/A Amended quarterly report Mar 6, 2012 Sep 30, 2011
CORRESP Letter to the SEC Mar 6, 2012 —
8-K Current report
Restatement
 Mar 2, 2012 Feb 28, 2012
CORRESP Letter to the SEC Feb 28, 2012 —
CORRESP Letter to the SEC Feb 13, 2012 —
CORRESP Letter to the SEC Jan 17, 2012 —
8-K Current report
Shareholder vote results
 Dec 30, 2011 Dec 22, 2011
CORRESP Letter to the SEC Dec 29, 2011 —
UPLOAD Letter from the SEC Dec 16, 2011 —
DEFA14A Additional proxy material Nov 23, 2011 —
CORRESP Letter to the SEC Nov 17, 2011 —
DEF 14A Proxy statement Nov 14, 2011 Dec 22, 2011
10-Q Quarterly report Nov 10, 2011 Sep 30, 2011
UPLOAD Letter from the SEC Nov 2, 2011 —
CORRESP Letter to the SEC Oct 24, 2011 —
CORRESP Letter to the SEC Sep 23, 2011 —
UPLOAD Letter from the SEC Sep 13, 2011 —
10-Q/A Amended quarterly report Sep 6, 2011 Jun 30, 2011
CORRESP Letter to the SEC Aug 19, 2011 —
CORRESP Letter to the SEC Aug 16, 2011 —
10-Q Quarterly report Aug 10, 2011 Jun 30, 2011
CORRESP Letter to the SEC Aug 3, 2011 —
UPLOAD Letter from the SEC Jul 25, 2011 —
8-K Current report
Officer or director change
 Jun 1, 2011 May 25, 2011
10-Q Quarterly report May 10, 2011 Mar 31, 2011
10-K/A Amended annual report Mar 17, 2011 Dec 31, 2010
10-Q/A Amended quarterly report Mar 15, 2011 Sep 30, 2010
10-Q/A Amended quarterly report Mar 15, 2011 Jun 30, 2010
10-Q/A Amended quarterly report Mar 15, 2011 Mar 31, 2010
10-K Annual report Mar 3, 2011 Dec 31, 2010
8-K Current report
Shareholder vote results
 Dec 29, 2010 Dec 22, 2010
DEFA14A Additional proxy material Nov 12, 2010 —
DEF 14A Proxy statement Nov 12, 2010 Dec 22, 2010
10-Q Quarterly report Nov 10, 2010 Sep 30, 2010
10-Q Quarterly report Aug 9, 2010 Jun 30, 2010

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CPHI (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Hainan Province, China
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1106644
Former names
TS ELECTRONICS INC (until May 4, 2006); SOFTSTONE INC (until Aug 18, 2003); SOFTSTONE INC /DE/ (until Jan 27, 2003); KILKENNY ACQUISITION CORP (until Mar 30, 2001)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.